If you look at patent US20090175865, there on page 36 is, in my opinion, sufficient explanation that the stretcher is a linker fragment that can consist of: the stretcher unit, a peptide fragment, and a spacer unit. The stretcher is most often a fragment of polyethylene glycol containing up to 24 units, and its role is to reduce the hydrophobicity of the antibody.